Related Experiment Video
Updated: Sep 6, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Do We Need Gadolinium-Based Contrast Agents for Routine MRI Surveillance of Unoperated Pituitary Macroadenoma?
A A Alali1, P B Hanagandi2, P J Maralani3
1From the Division of Neuroradiology (A.A.A.), King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia aliak@ksau-hs.edu.sa.
Background And Purpose:
The use of gadolinium-based contrast agents contributes to the cost of MR imaging and prolongs image-acquisition time. There are also recent concerns regarding gadolinium deposition, particularly in patients who require frequent follow-up MRIs. The purpose of this study was to assess whether gadolinium-based contrast agents are needed during MR imaging follow-up for unoperated pituitary macroadenoma.
Materials And Methods:
A total of 105 patients with unoperated pituitary macroadenoma who underwent follow-up MR imaging of the sella were included in this retrospective study. The craniocaudal dimension, cavernous sinus invasion grading, and optic pathway compression were assessed independently on coronal T2WI and compared with coronal T1-weighted images with gadolinium-based contrast agents (T1 postcontrast images). The agreement between the T2WI and T1 postcontrast images for the craniocaudal dimension was assessed using the intraclass correlation coefficient; for the cavernous sinus invasion and optic pathway compression, it was assessed using κ statistics.
Results:
There was excellent agreement for the craniocaudal dimensions between T2WI and T1 postcontrast images (intraclass correlation coefficient = 0.96, P < .001; 95% CI, 0.84-0.99). Additionally, there was almost-perfect agreement between cavernous sinus invasion and optic pathway compression between T2WI and T1 postcontrast images, with κ = 0.95 and 0.84, respectively (P < .001).
Conclusions:
MR imaging of the sella without the use of gadolinium-based contrast agents could potentially be considered for the follow-up of unoperated pituitary macroadenomas. This choice can reduce the MR imaging examination cost and acquisition time and avoids potential adverse effects of gadolinium-based contrast agents.
Insights
Gadolinium-based contrast agents may not be necessary for pituitary macroadenoma follow-up MRIs. Omitting these agents can reduce costs, shorten scan times, and avoid gadolinium deposition risks.
Area of Science:
- Radiology
- Neuroimaging
- Oncology
Background:
- Gadolinium-based contrast agents (GBCAs) increase MRI costs and scan times.
- Concerns exist regarding gadolinium deposition, especially with frequent MRI follow-ups.
- Pituitary macroadenomas require regular monitoring via MRI.
Purpose of the Study:
- To evaluate the necessity of GBCAs for follow-up MR imaging of unoperated pituitary macroadenomas.
- To determine if non-contrast MRI sequences are sufficient for monitoring tumor progression.
Main Methods:
- Retrospective analysis of 105 patients with unoperated pituitary macroadenomas.
- Comparison of coronal T2-weighted imaging (T2WI) with contrast-enhanced T1-weighted imaging (T1 postcontrast).
- Assessment of craniocaudal dimension, cavernous sinus invasion, and optic pathway compression using intraclass correlation coefficient and κ statistics.
Main Results:
- Excellent agreement (ICC = 0.96) for craniocaudal dimensions between T2WI and T1 postcontrast images.
- Almost-perfect agreement (κ = 0.95 and 0.84) for cavernous sinus invasion and optic pathway compression, respectively.
- High concordance suggests T2WI alone is reliable for key measurements.
Conclusions:
- MRI without GBCAs is a viable option for pituitary macroadenoma follow-up.
- Eliminating GBCAs reduces examination costs and acquisition time.
- This approach mitigates potential risks associated with gadolinium deposition.
More Related Videos
Related Concept Videos
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Magnetic Resonance Imaging
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies III: Computed Tomography
Radiological Investigation I: X-ray and CT

